pharma
dog
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
News
when
Latest
Archive
by source
All Sources
Sources Page
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
88
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
QA-102
Dry (Atrophic) Macular Degeneration
Guangzhou Yinming Biomedical Technology Co Ltd
1 cat
Phase 2
(difluprednate + povidone iodine)
(difluprednate + povidone iodine [USP])
Viral Conjunctivitis
iView Therapeutics Inc
Phase 2
A-197
Keratoconjunctivitis Sicca (Dry Eye)
Aramis Biosciences Inc
Phase 2
← prev
page 1 of 3
next →
131
Pain
89
Neurology
1
AAVB-039
Juvenile Macular Degeneration (Stargardt Disease)
AAVantgarde Bio Srl
Phase 2
ABI-110
Polypoidal Choroidal Vasculopathy
Avirmax Inc
Phase 2
ACDN-01
Juvenile Macular Degeneration (Stargardt Disease)
Ascidian Therapeutics Inc
Phase 2
ANXV
Retinal Vein Occlusion
Annexin Pharmaceuticals AB
Phase 2
ASP-7316
Juvenile Macular Degeneration (Stargardt Disease)
Astellas Pharma Inc
Phase 2
ATSN-101
Leber Congenital Amaurosis (LCA)
Atsena Therapeutics Inc
Phase 2
BRM-424
Neurotrophic Keratitis
BRIM Biotechnology Inc
Phase 2
BS-01
Retinitis Pigmentosa (Retinitis)
Beacon Therapeutics Ltd
Phase 2
CAM-101
Elate Ocular
Keratoconjunctivitis Sicca (Dry Eye)
Cambium Bio Limited
Phase 2
CBT-004
Unspecified Ophthalmological Disorders
Cloudbreak Therapeutics LLC
Phase 2
CBT-006
Keratoconjunctivitis Sicca (Dry Eye)
Cloudbreak Therapeutics LLC
Phase 2
CSB-001
Neurotrophic Keratitis
Claris Biotherapeutics Inc
Phase 2
CTx-001
Geographic Atrophy
Complement Therapeutics Ltd
Phase 2
CTxPDE-6b
Retinitis Pigmentosa (Retinitis)
Coave Therapeutics
Phase 2
DF-003
Chronic Kidney Disease (Chronic Renal Failure)
Drug Farm Inc
Phase 2
DSP-3077
Retinitis Pigmentosa (Retinitis)
Sumitomo Pharma Co Ltd
Phase 2
DT-168
Fuchs Endothelial Corneal Dystrophy (FECD)
$DSGN
Design Therapeutics, Inc.
Phase 2
GLK-221
Keratoconus
$GKOS
GLAUKOS Corp
Phase 2
GLK-302
pilocarpine
Presbyopia
$GKOS
GLAUKOS Corp
Phase 2
GLK-321
Demodex Blepharitis
$GKOS
GLAUKOS Corp
Phase 2
GLK-401
Age Related Macular Degeneration
$GKOS
GLAUKOS Corp
Phase 2
GRF-312
Keratoconjunctivitis Sicca (Dry Eye)
$GRFS
Grifols SA
Phase 2
GS-030
Retinitis Pigmentosa (Retinitis)
GenSight Biologics SA
Phase 2
Gene Therapy to Activate Retinoschisin for X-Linked Retinoschisis
Retinal Degeneration
National Eye Institute
Phase 2
H-1337
Open-Angle Glaucoma
D. Western Therapeutics Institute Inc
Phase 2
IC-265
Allergic Conjunctivitis
IACTA Pharmaceuticals Inc
Phase 2
IC-270
Allergic Conjunctivitis
IACTA Pharmaceuticals Inc
